title: Cardiovascular risk in androgen suppression: underappreciated, under-researched and unresolved.
authors.forename: Liam
authors.initials: L
authors.lastname: Bourke
authors.forename: Timothy J A
authors.initials: TJ
authors.lastname: Chico
authors.forename: Peter C
authors.initials: PC
authors.lastname: Albertsen
authors.forename: Freddie C
authors.initials: FC
authors.lastname: Hamdy
authors.forename: Derek J
authors.initials: DJ
authors.lastname: Rosario
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D015994:Incidence; D008297:Male; D011471:Prostatic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D000726:Androgen Antagonists